MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
19.14
+0.16 (0.84%)
Mar 12, 2026, 4:00 PM EDT - Market closed
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $835.3 million as of March 12, 2026.
Market Cap
835.30M
Enterprise Value
614.13M
1-Year Change
n/a
Ranking
Category
Stock Price
$19.14
Market Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has increased from $704.29M to $835.30M, an increase of 18.60%. That is a compound annual growth rate of 58.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 835.30M | 8.97% |
| Dec 31, 2025 | 766.56M | 8.84% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MannKind | 868.84M |
| Cullinan Therapeutics | 866.13M |
| Arvinas | 862.19M |
| Janux Therapeutics | 856.51M |
| Omeros | 845.84M |
| Evommune | 842.83M |
| Sana Biotechnology | 840.63M |
| ARS Pharmaceuticals | 832.11M |